Gwendlyn Kollmorgen

Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum

Andréa Lessa Benedet, Marta Milà‐Alomà, Agathe Vrillon et al. · JAMA Neurology · 2021 · 566 citations · Full text

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s <i>continuum</i> when only subtle changes in Aβ pathology are detected

Marc Suárez‐Calvet, Thomas K. Karikari, Nicholas J. Ashton et al. · EMBO Molecular Medicine · 2020 · 392 citations · Full text

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's <i>continuum</i>

Marta Milà‐Alomà, Gemma Salvadó, Juan Domingo Gispert et al. · Alzheimer s & Dementia · 2020 · 245 citations · Full text

An accurate fully automated panel of plasma biomarkers for Alzheimer's disease

Sebastian Palmqvist, Erik Stomrud, Nicholas Cullen et al. · Alzheimer s & Dementia · 2022 · 159 citations · Full text

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum

Carol Van Hulle, Erin M. Jonaitis, Tobey J. Betthauser et al. · Alzheimer s & Dementia · 2020 · 145 citations · Full text